Combined Antiplatelet/Anticoagulant Drug for Cardiac Ischemia/Reperfusion Injury

Circ Res. 2020 Oct 9;127(9):1211-1213. doi: 10.1161/CIRCRESAHA.120.317450. Epub 2020 Aug 17.
No abstract available

Keywords: mice; myocardial infarction; reperfusion; thrombosis; tick anticoagulant peptide.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anticoagulants / therapeutic use
  • Arthropod Proteins / genetics
  • Arthropod Proteins / therapeutic use*
  • Humans
  • Integrin beta3 / metabolism
  • Intercellular Signaling Peptides and Proteins / genetics
  • Intercellular Signaling Peptides and Proteins / therapeutic use*
  • Male
  • Mice, Inbred C57BL
  • Myocardial Reperfusion Injury / prevention & control*
  • Platelet Activation
  • Platelet Adhesiveness*
  • Platelet Aggregation Inhibitors / therapeutic use
  • Platelet Aggregation*
  • Platelet Membrane Glycoprotein IIb / metabolism
  • Random Allocation
  • Recombinant Fusion Proteins / therapeutic use*
  • Single-Chain Antibodies / genetics
  • Single-Chain Antibodies / metabolism
  • Single-Chain Antibodies / therapeutic use*
  • Thrombosis / etiology

Substances

  • Anticoagulants
  • Arthropod Proteins
  • Integrin beta3
  • Intercellular Signaling Peptides and Proteins
  • Platelet Aggregation Inhibitors
  • Platelet Membrane Glycoprotein IIb
  • Recombinant Fusion Proteins
  • Single-Chain Antibodies
  • tick anticoagulant peptide